{"id":205624,"name":"ZAMBON USA","slug":"zambon-usa","state":"CA","country":"United States of America","description":"Clinical stage biopharmaceutical company specializing in advanced inhaled therapeutics","totalSpending":244000,"filings":14,"yearlySpending":[{"year":2020,"income":60000},{"year":2021,"income":84000},{"year":2022,"income":100000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"},{"code":"VET","display":"Veterans"}],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON","KATHERINE LANDES","JACOB JACKSON","ALEXANDER ROOT"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures","Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures","Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures, Coverage Decisions","H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019\n\nS.4010/H.R. 4439 - Creating Hope Reauthorization Act","Drug pricing"]}